Screener
Roivant Sciences ROIV EBITDA
Discontinued — last reported Q1 '26
EBITDA at other companies
Other financials
Where this comes from
Calculated from Roivant Sciences’s reported figures.
The source filing: Roivant Sciences’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 7:28 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001635088-26-000090
FAQ
- What is Roivant Sciences's EBITDA?
- Roivant Sciences (ROIV) reported EBITDA of -$365.39M in Q2 2026.
- How has Roivant Sciences's EBITDA changed year-over-year?
- Roivant Sciences's EBITDA decreased by 28.7% year-over-year, from -$283.82M to -$365.39M.
- What is the long-term trend for Roivant Sciences's EBITDA?
- Over 2 years (2022 to 2024), Roivant Sciences's EBITDA has grown at a 3.6% compound annual growth rate (CAGR), from -$922.3M to -$989.22M.
- What does EBITDA mean?
- Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.
Ask your AI about Roivant Sciences's ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude